Central & Western Europe
Austria — BASG
Belgium — FAMHP / FAGG
France — ANSM
Germany — BfArM and PEI
Ireland — HPRA
Luxembourg — Ministry of Health
Netherlands — CBG-MEB
CTIS & Europe
CTIS is the single entry point for medicinal-product clinical-trial applications under the EU Clinical Trials Regulation.
CTIS supports interactions between sponsors and regulatory authorities across EU Member States and EEA countries. National competent authorities and ethics committees participate in assessment. The UK and Switzerland follow separate national routes.
Terminology index only. Check current national requirements before every submission.
Austria — BASG
Belgium — FAMHP / FAGG
France — ANSM
Germany — BfArM and PEI
Ireland — HPRA
Luxembourg — Ministry of Health
Netherlands — CBG-MEB
Denmark — DKMA
Estonia — State Agency of Medicines
Finland — Fimea
Iceland — Icelandic Medicines Agency
Latvia — State Agency of Medicines
Lithuania — SMCA
Norway — Norwegian Medical Products Agency
Sweden — MPA
Bulgaria — BDA
Croatia — HALMED
Czechia — SÚKL
Greece — EOF
Hungary — NNGYK
Italy — AIFA
Malta — Medicines Authority
Poland — URPL
Portugal — INFARMED
Romania — ANMDMR
Slovakia — ŠÚKL
Slovenia — JAZMP
Spain — AEMPS